The largest database of trusted experimental protocols

Nanoject 2 auto nanoliter injector

Manufactured by Drummond
Sourced in United States

The Nanoject II Auto-Nanoliter Injector is a laboratory instrument designed for the precise microinjection of small volumes of liquids. It is capable of delivering nanoliter-scale volumes with high accuracy and repeatability.

Automatically generated - may contain errors

80 protocols using nanoject 2 auto nanoliter injector

1

Oral Microgavage and Cardiac Injection in Larval Zebrafish

Check if the same lab product or an alternative is used in the 5 most similar protocols
For oral microgavage, larval zebrafish were anesthetized, mounted in sterile 4% methylcellulose and gavaged as described previously (Cocchiaro and Rawls, 2013 ). Proteins were administered to each larval zebrafish with a 4.6 nL volume at an injection rate of 23 nL/sec using a Nanoject II Auto-Nanoliter Injector (Drummond Scientific Company, Broomall, PA). To visualize the global localization of BefA in vivo, mCh-BefA, mCh, mNG-BefA, or mNG were administered at a concentration of 1 mg/mL. All images were taken no longer than 2 hrs after gavage using the wide-field feature of a LEICA DM6 confocal microscope (Leica Microsystems Inc., Buffalo Grove, IL).
For cardiac valley injections, 4 dpf larval zebrafish were anesthetized and injected directly into the cardiac valley with 2 pg of BefA or negative control vehicle again using the Nanoject II Auto-Nanoliter Injector (Drummond Scientific Company, Broomall, PA) as previously described (Wiles et al., 2009 (link)). Zebrafish were revived and housed in separate wells of a 24-well plate after the injection to monitor health. To ensure that gavaged or injected GF larvae were not contaminated with microbes during these procedures, a sample of embryo media and homogenized gastrointestinal tracts from some larvae were plated onto tryptic soy agar (TSA) or luria broth (LB) agar at the time of harvest, typically 48 hrs later.
+ Open protocol
+ Expand
2

Mosquito Barriers and SHUV Dissemination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adult female Cx. p. pipiens (3–9 days old) and Ae. aegypti (4–6 days old) mosquitoes were injected with SHUV into the thorax to investigate the role of mosquito barriers on dissemination of SHUV. Mosquitoes were anesthetized with 100% CO2 and positioned on the CO2-pad. Female mosquitoes were intrathoracically injected with 69 nl of SHUV (P3 stock with a titer of 3.0 x 106 TCID50/ml) using a Drummond Nanoject II Auto-Nanoliter injector (Drummond Scientific, Broomall, Unites States). Injected Cx. p. pipiens were maintained at 25°C and injected Ae. aegypti were maintained at 28°C. Mosquitoes were incubated for 10 days at the respective temperatures, and had access to 6% glucose solution ad libitum. Injections were done during a single replicate experiment for Cx. p. pipiens (N = 50) and Ae. aegypti (N = 50).
+ Open protocol
+ Expand
3

Mosquito Infections with Zika and Usutu Viruses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female mosquitoes were immobilized with CO2 prior to intrathoracic injection using a Drummond Nanoject II Auto-Nanoliter Injector (Drummond Scientific, Broomall, PA, USA). Cx. pipiens molestus was injected with 1.0 × 104 TCID50 of ZIKV or 3.5 × 103 TCID50 of USUV (positive control). Cx. pipiens pipiens was injected with decreasing doses of ZIKV containing 1.0 × 104, 1.0 × 102 or 3.0 × 101 TCID50, or with 3.5 × 103 TCID50 of USUV (positive control). Ae. aegypti was injected with 1.0 × 104 TCID50 of ZIKV (positive control). The injected mosquitoes were incubated at 28 °C with access to 6% glucose.
+ Open protocol
+ Expand
4

Zika and Usutu Virus Infection in Mosquitoes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ae. japonicus females received a 69 nl ZIKV injection of 4.4 x 103 TCID50 (mosquitoes collected in 2018) or 1.0 x 104 TCID50 (mosquitoes collected in 2017), or a 69 nl USUV injection of 3.5 x 103 TCID50 in the thorax. Ae. aegypti females were injected with a 69 nl ZIKV injection of 1.0 x 104 TCID50. Mosquitoes were immobilised with 100% CO2, and injected using a Drummond Nanoject II Auto-Nanoliter Injector (Drummond Scientific, Broomall, PA, USA) with a glass needle. Injected mosquitoes were kept at 28°C and 12:12 light:dark period for 14 days, and received 6% glucose solution as a food source.
+ Open protocol
+ Expand
5

Arboviruses dissemination in mosquitoes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adult female Cx. p. pipiens (3–9 days old) and Ae. aegypti (4–6 days old) mosquitoes were injected with SHUV into the thorax to investigate the role of mosquito barriers on dissemination of SHUV. Mosquitoes were anesthetized with 100% CO2 and positioned on the CO2-pad. Female mosquitoes were intrathoracically injected with 69 nl of SHUV (P3 stock with a titer of 3.0 x 106 TCID50/ml) using a Drummond Nanoject II Auto-Nanoliter injector (Drummond Scientific, Broomall, Unites States). Injected Cx. p. pipiens were maintained at 25°C and injected Ae. aegypti were maintained at 28°C. Mosquitoes were incubated for 10 days at the respective temperatures, and had access to 6% glucose solution ad libitum. Injections were done during a single replicate for Cx. p. pipiens (N = 50) and Ae. aegypti (N = 50).
+ Open protocol
+ Expand
6

Mosquito Immune Stimulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mosquitoes were anesthetized by placing them in a −20 °C environment for 30–40 sec and then transferred to a Petri dish placed on top of ice. For both primary and secondary treatments, a finely pulled capillary glass needle was inserted into the hemocoel through the thoracic anepisternal cleft, and 69 nL of a solution were injected under the control of a Nanoject II Auto-Nanoliter Injector (Drummond Scientific Company, Broomall, PA, USA). The mosquitoes were then returned to 27 °C. The mosquitoes were injected with either sterile Luria–Bertani’s rich nutrient medium (LB broth; injury) or with bacteria in LB broth (infection). Other mosquitoes were anesthetized but otherwise left unmanipulated (naïve).
Bacterial infections were conducted using two strains of E. coli: a parental K12 strain (E. coli-K12) and a derived DH5 alpha strain that was tetracycline-resistant and expressed GFP (E. coli-GFP). Both strains were grown overnight in LB broth at 37 °C in a shaking incubator, the absorbance of each culture was measured using a Biophotometer Plus spectrophotometer (Eppendorf, Hamburg, Germany) and normalized to OD600 = 2, and the culture was injected into the hemocoel.
+ Open protocol
+ Expand
7

Xenopus Embryo Collection and Microinjection

Check if the same lab product or an alternative is used in the 5 most similar protocols
To obtain X. laevis embryos, female frogs were induced to ovulate by injecting 500 to 700 U of human chorionic gonadotropin subcutaneously, directly above the dorsal lymph sacs. After injection, females were maintained in the dark at 18°C overnight. After females began ovulating the following morning, one male was euthanized by placing it in 0.1% tricaine solution buffered with sodium bicarbonate for 30 min. Both testes were dissected and placed into a 35-mm dish containing 1.5 ml of 1× Mark’s modified ringer (MMR) solution [0.1 M NaCl, 2 mM KCl, 1 mM MgSO4, 2 mM CaCl2, and 5 mM Hepes (pH 7.8)]. Eggs were gently squeezed from females into 10-cm plates. Sperm were released to fertilize the eggs by mincing a small portion of the testes in a few drops of 1× MMR placed beside the eggs followed by gentle mixing of eggs and sperm together. After 10 min at room temperature (RT), the fertilized eggs were flooded with 0.1× MMR solution (pH 7.4). Embryos were dejellied using 2% l-cysteine solution (pH 7.8) for 2 min. Embryos were washed thrice with 0.1× MMR solution and placed in 0.1× MMR. At the desired developmental stage, embryos were injected with a Nanoject II Auto-Nanoliter Injector (Drummond Scientific Inc.). Injected embryos were maintained in 4% Ficoll/0.1% MMR solution at 18°C until they reached stage 9 and then transferred to 0.1× MMR buffer.
+ Open protocol
+ Expand
8

Xenopus Oocyte mRNA Injection Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Xenopus laevis ooctyes were provided by Ecocyte Bioscience. mRNA (0.5ng, 50 nL) was injected into oocytes with a Nanoject II Auto-Nanoliter Injector (Drummond, 3–000-204) and oocytes were incubated in modified barth’s solution (MBS, Ecocyte Bioscience LRE-S-LSG-1006–7) at 18oC for 48 hrs before recording.
+ Open protocol
+ Expand
9

RNAi-Mediated Silencing of Mosquito Immune Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA interference was performed as previously described (Povelones et al., 2011 (link); Schleicher et al., 2018 (link)). dsRNA targeting mosGILT, TEP1, CTL4, or an irrelevant luc gene from Renilla reniformis (Schleicher et al., 2018 (link)), were transcribed using the MEGAScript RNAi kit (Thermo Fisher Scientific, Ambion; primers in Table S1).
2-d-old A. gambiae mosquitoes were injected with dsRNA using a Nanoject II Auto-Nanoliter Injector (Drummond) and allowed to recover in paper cups with 10% sucrose for 2 d. For silencing of CTL4 or TEP1, 0.35 µg of total dsRNA was used for each mosquito. For silencing of mosGILT, 1.0 µg of total dsRNA was injected into each mosquito. On day 4 after dsRNA injection, these mosquitoes were deprived of sucrose for 20 h before allowing them to feed on P. berghei–infected mice with 3–5% parasitemia. Unfed mosquitoes were immediately discarded, and the fed remaining mosquitoes were maintained with 10% sucrose containing 0.05% penicillin/streptomycin for 8 d at 20°C. On day 8 after infection, oocysts and melanized ookinetes in the midgut were counted as mentioned above.
+ Open protocol
+ Expand
10

Quantifying Zebrafish Angiogenesis via SIV Branching

Check if the same lab product or an alternative is used in the 5 most similar protocols
A transgenic zebrafish line Tg(fli1a:EGFP)y1 was used to assess in vivo angiogenesis as previously described [33 (link)]. Briefly, zebrafish embryos were generated by natural pairwise mating and cultured in embryo water (0.2 g/L Instant Ocean Salt) at 28°C. Dead or unfertilized embryos were discarded after 8 hours post-fertilization (hpf). Working dilution of CEP (100 and 200 μM in PBS containing 1% DMSO) or cholesterol-cyclodextrin complex (800 μg/mL cholesterol in 10% methyl-β-cyclodextrin) was directly injected into embryos with Nanoject II Auto-Nanoliter Injector (Drummond Scientific Company, Broomall, PA) with an injection volume of 4.6 nL. The embryos were dechorionated manually at 24 hpf and N-phenylthiourea (PTU) (Sigma-Aldrich) at a final concentration of 3 mg/mL was added into the embryos. The embryos were incubated for 72 h and observed the formation of subintestinal vessels (SIVs) under a Carl Zeiss LSM 710 confocal microscope. The zebrafish angiogenesis was quantified by counting the number of SIV branch points.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!